Neogen | NEOG - Operating Expenses


Neogen reported $230.07M in Operating Expenses for its fiscal quarter ending in September of 2025.





Operating Expenses Change Date
Agilent USD 1.42B 57M Sep/2025
Avanos Medical USD 158.83M 69.83M Sep/2025
Bio-Rad Laboratories USD 6.74B 6.16B Sep/2025
Cerus USD 34.78M 2.98M Dec/2024
Danaher USD 5.34B 45.74B Dec/2025
Idexx Laboratories USD 774.97M 24.58M Dec/2025
Illumina USD 903M 69M Dec/2025
Integra LifeSciences USD 1.04B 620.66M Sep/2025
Neogen USD 230.07M 4.79M Sep/2025
OraSure Technologies USD 23.07M 4.36M Sep/2024
Pacific Biosciences Of California USD 74.08M 107.7M Sep/2024
Quidel USD 760.9M 1.28B Dec/2025
Rockwell Medical USD 30.41M 1.11M Jun/2025
STAAR Surgical USD 69.04M 8.29M Jun/2025
Surmodics USD -245.35M 363.49M Sep/2024
Thermo Fisher Scientific USD 9.91B 867M Dec/2025
Utah Medical Products USD 6.25M 80K Sep/2024
Zoetis USD 1.55B 3.85B Dec/2025